Cargando…

Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells

Glioblastoma (GBM) is a poorly treatable disease due to the fast development of tumor recurrences and high resistance to chemo- and radiotherapy. To overcome the highly adaptive behavior of GBMs, especially multimodal therapeutic approaches also including natural adjuvants have been investigated. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellmold, Dana, Kubelt, Carolin, Daunke, Tina, Beckinger, Silje, Janssen, Ottmar, Hauck, Margarethe, Schütt, Fabian, Adelung, Rainer, Lucius, Ralph, Haag, Jochen, Sebens, Susanne, Synowitz, Michael, Held-Feindt, Janka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218802/ https://www.ncbi.nlm.nih.gov/pubmed/37240419 http://dx.doi.org/10.3390/ijms24109075

Ejemplares similares

Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience
por: Kubelt, Carolin, et al.
Publicado: (2023)

Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release
por: Hauck, Margarethe, et al.
Publicado: (2022)

Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma
por: Kubelt, Carolin, et al.
Publicado: (2023)

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche
por: Caylioglu, Deniz, et al.
Publicado: (2021)

Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1
por: Adamski, Vivian, et al.
Publicado: (2020)

Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment
por: Adamski, Vivian, et al.
Publicado: (2017)

Influence of Simulated Deep Brain Stimulation on the Expression of Inflammatory Mediators by Human Central Nervous System Cells In Vitro
por: Kubelt, Carolin, et al.
Publicado: (2021)

AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy
por: Flak, Dorota K, et al.
Publicado: (2020)

Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers
por: Kubelt, Carolin, et al.
Publicado: (2020)

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
por: Beckinger, Silje, et al.
Publicado: (2023)

The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
por: Adamski, Vivian, et al.
Publicado: (2017)

Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control
por: Heckl, Steffen M., et al.
Publicado: (2021)

Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation
por: Böttcher, Marvin A., et al.
Publicado: (2018)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023)

Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA‐101 in glioblastoma
por: Cai, Tao, et al.
Publicado: (2018)

Dormancy and NKG2D system in brain metastases: Analysis of immunogenicity
por: Flüh, Charlotte, et al.
Publicado: (2020)

Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer
por: Mehdorn, Anne-Sophie, et al.
Publicado: (2022)

NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
por: Chitadze, Guranda, et al.
Publicado: (2015)

Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas
por: Adamski, Vivian, et al.
Publicado: (2017)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells
por: Hattermann, Kirsten, et al.
Publicado: (2014)

Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
por: Hattermann, Kirsten, et al.
Publicado: (2016)

Microengineered Hollow Graphene Tube Systems Generate Conductive Hydrogels with Extremely Low Filler Concentration
por: Arndt, Christine, et al.
Publicado: (2021)

“Inverse signaling” of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells
por: Hattermann, Kirsten, et al.
Publicado: (2016)

Evaluation of a Brown Seaweed Extract from Dictyosiphon foeniculaceus as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma
por: Dörschmann, Philipp, et al.
Publicado: (2020)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses
por: Rickert, Uta, et al.
Publicado: (2014)

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
por: Tian, Tian, et al.
Publicado: (2016)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
por: Yin, Jianxing, et al.
Publicado: (2023)

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
por: Miarka, Lauritz, et al.
Publicado: (2019)

MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
por: Chen, Rui, et al.
Publicado: (2016)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices
por: Schmitt, Christina, et al.
Publicado: (2020)

Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells
por: Cheng, Quan, et al.
Publicado: (2017)

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
por: Zhang, Zhuoran, et al.
Publicado: (2019)

Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
por: Yao, Lei, et al.
Publicado: (2022)

Chemokine-Ligands/Receptors: Multiplayers in Traumatic Spinal Cord Injury
por: Knerlich-Lukoschus, Friederike, et al.
Publicado: (2015)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r03ct3is3co1g3n1g0dhpqnldp